Overview

A Study To Evaluate The Contact Sensitization Potential Of Tazarotene Foam On Skin In Healthy Volunteers

Status:
Completed
Trial end date:
2010-06-26
Target enrollment:
Participant gender:
Summary
This study will assess the potential of tazarotene foam to cause sensitization during a 48 hour challenge following 21 days of exposure on the skin of healthy volunteers.
Phase:
Phase 1
Details
Lead Sponsor:
Stiefel, a GSK Company
Collaborator:
GlaxoSmithKline
Treatments:
Nicotinic Acids
Tazarotene